Global Acute Ischemic Stroke Diagnosis and Treatment Market US$ 1.8 Billion by 2021

Global Acute Ischemic Stroke Diagnosis and Treatment Market US$ 1.8 Billion by 2021

Acute ischemic stroke is characterized by the sudden loss of blood circulation to an area of the brain, resulting in a corresponding loss of neurologic function. Acute ischemic stroke is caused by thrombotic or embolic occlusion of a cerebral artery and is more common than hemorrhagic stroke. Different imaging studies, including computed tomography, magnetic resonance imaging, computed tomographic angiography, magnetic resonance angiography, and perfusion studies, are useful for evaluation of acute stroke.

Acute Ischemic Stroke Diagnosis and Treatment Market 2017-2021 report estimates the global acute ischemic stroke diagnosis and treatment market to reach nearly US$ 1.7 Billion in 2020, at a CAGR of 5.5% from 2017 to 2021 – iHealthcareAnalyst, Inc.

Visit the Acute Ischemic Stroke Diagnosis and Treatment Market 2017-2021 report https://www.ihealthcareanalyst.com/report/acute-ischemic-stroke-diagnosis-and-treatment-market/

The global acute ischemic stroke diagnosis and treatment market report provides market size (Revenue US$ Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021).

The global acute ischemic stroke diagnosis and treatment market segmentation is based on diagnostics type (computed tomography, magnetic resonance imaging, ultrasound, cerebral angiography, nuclear imaging), and surgery types (carotid endarterectomy, angioplasty, endovascular mechanical thrombectomy). The global acute ischemic stroke diagnosis and treatment market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

1. Diagnostics Type
1.1 Computed Tomography
1.2 Magnetic Resonance Imaging
1.3 Ultrasound
1.4 Cerebral Angiography
1.5 Nuclear Imaging
1.6 Others

2. Surgery Type
2.1 Carotid Endarterectomy
2.2 Angioplasty
2.3 Endovascular Mechanical Thrombectomy

3. Geography (Region, Country)
3.1 North America (U.S., Canada)
3.2 Latin America (Brazil, Mexico, Rest of LA)
3.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4 Asia Pacific (Japan, China, India, Rest of APAC)
3.5 Rest of the World

4. Company Profiles
4.1 Abbott Laboratories
4.2 Covidien PLC
4.3 Johnson & Johnson
4.4 Penumbra, Inc.
4.5 Philips Healthcare
4.6 GE Healthcare
4.7 Hitachi, Ltd.
4.8 Siemens Healthcare
4.9 Stryker Corporation

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: [email protected]
Website: http://www.ihealthcareanalyst.com

2017-11-05T09:56:40+00:00 Categories: Press Releases|